1,4-dihydropyridine-3,5-dicarboxylic acid esters in treatment of neuronal diseases

US5665741A · kind A · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Klaus Urbahns · Kasai, JP
• Otto Behner · Wuppertal, DE
• Siegfried Goldmann · Wuppertal, DE
• Hans-Georg Heine · Krefeld, DE
• Bodo Junge · Wuppertal, DE
• Rudolf Schohe-Loop · Wuppertal, DE
• Egbert Wehinger
• Hartmund Wollweber · Wuppertal, DE
• Henning Sommermeyer · Neunburg vorm Wald, DE
• Thomas Glaser · Overath, DE
• Reilinde Wittka · Neunburg vorm Wald, DE
• Jean De Vry · Stolberg, DE

Key dates

• Filing date: Aug 18, 1995
• Grant date: Sep 9, 1997
• Expiry date: Aug 18, 2015

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to the use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters, some of which are known, of the general formula (I) ##STR1## in which A and R.sup.1 -R.sup.3 have the meaning given in the description, as medicaments, in particular for treatment of the central nervous system, and new selected active compounds.